WO2002024700A3 - SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES - Google Patents

SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES Download PDF

Info

Publication number
WO2002024700A3
WO2002024700A3 PCT/US2001/029447 US0129447W WO0224700A3 WO 2002024700 A3 WO2002024700 A3 WO 2002024700A3 US 0129447 W US0129447 W US 0129447W WO 0224700 A3 WO0224700 A3 WO 0224700A3
Authority
WO
WIPO (PCT)
Prior art keywords
salts
compounds
indoline derivatives
azepino
substituted
Prior art date
Application number
PCT/US2001/029447
Other languages
French (fr)
Other versions
WO2002024700A2 (en
Inventor
Kristine E Frank
Jian-Min Fu
Brad A Acker
Michael D Ennis
Jed F Fisher
Eric Jon Jacobsen
William W Mcwhorter
Jeanette K Morris
Donald Joseph Rogier Jr
Original Assignee
Upjohn Co
Kristine E Frank
Fu Jian Min
Brad A Acker
Michael D Ennis
Jed F Fisher
Eric Jon Jacobsen
William W Mcwhorter
Jeanette K Morris
Donald Joseph Rogier Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co, Kristine E Frank, Fu Jian Min, Brad A Acker, Michael D Ennis, Jed F Fisher, Eric Jon Jacobsen, William W Mcwhorter, Jeanette K Morris, Donald Joseph Rogier Jr filed Critical Upjohn Co
Priority to JP2002529110A priority Critical patent/JP2004509893A/en
Priority to AU2001294606A priority patent/AU2001294606A1/en
Priority to EP01975267A priority patent/EP1319005A2/en
Publication of WO2002024700A2 publication Critical patent/WO2002024700A2/en
Publication of WO2002024700A3 publication Critical patent/WO2002024700A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention provides compounds of Formula (I): where R1-R4, p and q have any of the values described in the specification, as well as pharmaceutical salts thereof, and pharmaceutical compositions containing such compounds or salts. The compounds and salts are 5-HT ligands and are useful for treating diseases, disorders, and/or conditions in a mammal wherein activity of a 5-HT receptor is implicated. The compounds and salts are particularly useful for treating diseases of the central nervous system.
PCT/US2001/029447 2000-09-20 2001-09-20 SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES WO2002024700A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2002529110A JP2004509893A (en) 2000-09-20 2001-09-20 Substituted azepino [4,5b] indoline derivatives
AU2001294606A AU2001294606A1 (en) 2000-09-20 2001-09-20 Substituted azepino(4,5b)indoline derivatives
EP01975267A EP1319005A2 (en) 2000-09-20 2001-09-20 Substituted azepino[4,5-b]indoline derivatives

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23437600P 2000-09-20 2000-09-20
US60/234,376 2000-09-25
US26604701P 2001-02-01 2001-02-01
US60/266,047 2001-02-01
US30196401P 2001-06-29 2001-06-29
US60/301,964 2001-06-29

Publications (2)

Publication Number Publication Date
WO2002024700A2 WO2002024700A2 (en) 2002-03-28
WO2002024700A3 true WO2002024700A3 (en) 2002-06-13

Family

ID=27398561

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2001/029535 WO2002024701A2 (en) 2000-09-20 2001-09-20 Substituted azepino[4,5b)indole derivatives
PCT/US2001/029447 WO2002024700A2 (en) 2000-09-20 2001-09-20 SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2001/029535 WO2002024701A2 (en) 2000-09-20 2001-09-20 Substituted azepino[4,5b)indole derivatives

Country Status (7)

Country Link
US (4) US6586421B2 (en)
EP (2) EP1319005A2 (en)
JP (2) JP2004509894A (en)
AR (2) AR035493A1 (en)
AU (2) AU2001294606A1 (en)
PE (2) PE20020510A1 (en)
WO (2) WO2002024701A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409910B2 (en) 2008-10-31 2016-08-09 Medivation Technologies, Inc. Azepino[4,5-B]indoles and methods of use

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1575984A4 (en) * 2001-02-16 2006-09-06 Bristol Myers Squibb Co Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
EP1281700A1 (en) * 2001-07-31 2003-02-05 Resolution Research Nederland B.V. Manufacturing process for the preparation of alpha, alpha-branched alkane carboxylic acids providing esters with an improved softness
JP2005526691A (en) * 2001-08-08 2005-09-08 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Therapeutic agent 1H-pyrido [4,3-b] indole
US7595311B2 (en) * 2002-05-24 2009-09-29 Exelixis, Inc. Azepinoindole derivatives as pharmaceutical agents
TWI329111B (en) * 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents
AU2002950217A0 (en) * 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
US7592454B2 (en) * 2004-04-14 2009-09-22 Bristol-Myers Squibb Company Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
US7718647B2 (en) * 2004-06-30 2010-05-18 Athersys, Inc. Substituted azepine derivatives as serotonin receptor modulators
US8685924B2 (en) 2004-08-25 2014-04-01 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP1747779A1 (en) * 2005-07-28 2007-01-31 Laboratorios Del Dr. Esteve, S.A. Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands
NZ569554A (en) * 2006-01-19 2011-10-28 Athersys Inc Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof
JP5528699B2 (en) 2006-05-16 2014-06-25 武田薬品工業株式会社 Fused heterocyclic compounds and uses thereof
US20100209960A1 (en) * 2007-09-10 2010-08-19 Merck Sharp & Dohme Corp. Method for measuring mitochondrial membrane potential in vertebrate cells
US7816435B2 (en) * 2007-10-31 2010-10-19 Momentive Performance Materials Inc. Halo-functional silane, process for its preparation, rubber composition containing same and articles manufactured therefrom
EP2789338A3 (en) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Condensed pyridine derivate and use thereof
JP5501251B2 (en) 2008-01-11 2014-05-21 アルバニー モレキュラー リサーチ， インコーポレイテッド (1-Azinone) substituted pyridoindoles as MCH antagonists
US9625475B2 (en) 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
WO2010036998A2 (en) 2008-09-29 2010-04-01 Abbott Laboratories Indole and indoline derivatives and methods of use thereof
JP5588991B2 (en) 2008-10-31 2014-09-10 メディベイション テクノロジーズ， インコーポレイテッド Pyrido [4,3-b] indole with rigid part
US8637501B2 (en) 2009-07-01 2014-01-28 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
US8629158B2 (en) 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
JPWO2011071136A1 (en) 2009-12-11 2013-04-22 アステラス製薬株式会社 Fibromyalgia treatment
WO2011103485A1 (en) 2010-02-18 2011-08-25 Medivation Technologies, Inc. Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
WO2011103460A1 (en) 2010-02-18 2011-08-25 Medivation Technologies, Inc. Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]ondole derivatives and methods of use
WO2011103487A1 (en) * 2010-02-18 2011-08-25 Medivation Technologies, Inc. Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
WO2011103433A1 (en) 2010-02-18 2011-08-25 Medivation Technologies, Inc. Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
US9187471B2 (en) 2010-02-19 2015-11-17 Medivation Technologies, Inc. Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
BR112013021126A2 (en) 2011-02-18 2019-09-24 Medivation Technologies Inc method for reducing blood pressure, method for increasing renal blood flow or decreasing sodium reabsorption, method for treating a disease, kit, compound and pharmaceutical composition
WO2012112961A1 (en) * 2011-02-18 2012-08-23 Medivation Technologies, Inc. Compounds and methods of treating hypertension
US9199985B2 (en) 2011-02-18 2015-12-01 Medivation Technologies, Inc. Compounds and methods for treatment of hypertension
US20130178618A1 (en) * 2012-01-10 2013-07-11 William Allen Boulanger Novel pharmaceutical intermediates and methods for preparing the same
US20150315188A1 (en) * 2012-08-22 2015-11-05 Medivation Technologies, Inc. Compounds and methods for treatment of hypertension
CN110072518B (en) 2016-10-12 2021-10-26 细胞内治疗公司 Amorphous solid dispersion
JP7132939B2 (en) 2017-03-24 2022-09-07 イントラ－セルラー・セラピーズ・インコーポレイテッド Novel compositions and methods
JPWO2019131902A1 (en) 2017-12-27 2020-12-10 武田薬品工業株式会社 Remedies for stress urinary incontinence and fecal incontinence
MX2021002321A (en) 2018-08-31 2021-04-28 Intra Cellular Therapies Inc Novel methods.
CA3130770A1 (en) * 2019-02-27 2020-09-03 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders
EP3930708A4 (en) 2019-02-27 2023-02-15 The Regents Of The University Of California N-substituted indoles and other heterocycles for treating brain disorders
CN111053789A (en) * 2019-11-26 2020-04-24 湖南营养树生物科技有限公司 Methods and compositions for modulating the immune system
WO2023092045A1 (en) 2021-11-17 2023-05-25 Terran Biosciences, Inc. Salt and solid forms of tabernanthalog
TW202333668A (en) * 2021-12-15 2023-09-01 美商德利克斯醫療公司 Phenoxy and benzyloxy substituted psychoplastogens and uses thereof
WO2023212811A1 (en) * 2022-05-06 2023-11-09 Bright Minds Biosciences Inc. Azepinoindoles and methods of preparation thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466548A1 (en) * 1990-06-27 1992-01-15 Adir Et Compagnie 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indole and 1,2,3,4-tetrahydro-beta-carbolines, processes for their preparation, and pharmaceutical compositions containing them

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6699E (en) 1905-09-25 1907-01-31 Maurice Honore Firmin Muraire Silkworm cocoon threading machine
DE1062840B (en) 1953-03-03 1959-08-06 Siemens Reiniger Werke Ag Device for making visible, or for strengthening visible, images caused by corpuscular or wave radiation, in particular for x-ray fluoroscopy
CH445508A (en) * 1964-12-03 1967-10-31 Geigy Ag J R Process for the production of new indole derivatives
US3839357A (en) 1966-05-10 1974-10-01 Upjohn Co 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
GR35044B (en) 1966-05-10 1968-07-31 The Upjohn Company METHOD OF PREPARATION OF ORGANIC COMPOUNDS.
US3525750A (en) 1966-05-31 1970-08-25 Geigy Chem Corp 1,2,3,4,5,6-hexahydro-azepino(4,5-b) indole derivatives
US3553232A (en) 1967-08-25 1971-01-05 Upjohn Co 4-(1,4,5,6-tetrahydroazepine(4,5-b)indole-3(2h)-yl)butyrophenones
US3622673A (en) 1968-11-14 1971-11-23 Upjohn Co 4-(1,4,5,6-TETRAHYDROZEPINO 4,5-b INDOL-3(2H)-YL-BUTYROPHENON COMPOSITIONS AND PROCESS OF TREATMENT MENTAL OR EMOTIONAL DISORDERS
US3652588A (en) 1969-10-23 1972-03-28 Upjohn Co 6-alkyl-1 2 3 4 5 6-hexahydroazepino(4 5-b)indoles
US3676558A (en) 1970-08-28 1972-07-11 Upjohn Co Anorexigenic compositions comprising 6-alkyl-1,2,3,4,5,6-hexahydroazepino 4,5-indoles as active ingredient and process of treatment
US3776922A (en) * 1972-03-24 1973-12-04 J Epstein Indole carboxaldehydes
EP0028381B1 (en) * 1979-11-02 1985-04-10 Sandoz Ag Azepinoindoles, process for their production and pharmaceutical compositions containing them
CH649553A5 (en) * 1982-05-06 1985-05-31 Sandoz Ag AZEPINOINDOLS AND METHOD FOR THE PRODUCTION THEREOF.
JPS63163347A (en) 1986-12-25 1988-07-06 Konica Corp Method for preventing photodiscoloration of organic coloring substance
EP0377238A1 (en) 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
AR023574A1 (en) 1999-04-23 2002-09-04 Pharmacia & Upjohn Co Llc TETRACICLIC AZEPININDOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS TO PREPARE A MEDICINAL PRODUCT, AND INTERMEDIARIES
MXPA01012914A (en) 1999-06-15 2004-04-21 Bristol Myers Squibb Co Substituted heterocycle fused gamma-carbolines.
DE19929076A1 (en) 1999-06-25 2000-12-28 Aventis Pharma Gmbh New indanyl-substituted benzenesulfonamide derivatives, as potassium channel blockers useful as safe antiarrhythmic agents, e.g. for treating atrial fibrillation or flutter
MY122278A (en) 1999-07-19 2006-04-29 Upjohn Co 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
WO2002004456A1 (en) * 2000-07-06 2002-01-17 Pharmacia & Upjohn Company SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466548A1 (en) * 1990-06-27 1992-01-15 Adir Et Compagnie 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indole and 1,2,3,4-tetrahydro-beta-carbolines, processes for their preparation, and pharmaceutical compositions containing them

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BARKOV, N. K. ET AL: "Pharmacological properties of carazedine", XP002195043, retrieved from STN Database accession no. 121:49905 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; KUCHEROVA, N. F. ET AL: "3,9-Dimethyl-1,2,3,4,5,5a,6,10b-octahydroazepino[4,5-b]indole", XP002195045, retrieved from STN Database accession no. 69:59212 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SHARKOVA, N. M. ET AL: "Indole derivatives. XXVIV. Synthesis of some new polycondensed indole systems", XP002195044, retrieved from STN Database accession no. 70:115036 *
EKSP. KLIN. FARMAKOL. (1994), 57(2), 4-6 *
KHIM. GETEROTSIKL. SOEDIN. (1969), (1), 88-90 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409910B2 (en) 2008-10-31 2016-08-09 Medivation Technologies, Inc. Azepino[4,5-B]indoles and methods of use
US9481676B2 (en) 2008-10-31 2016-11-01 Medivation Technologies, Inc. Azepino[4,5-B]indoles and methods of use

Also Published As

Publication number Publication date
US20020077318A1 (en) 2002-06-20
AU2001294606A1 (en) 2002-04-02
AR034264A1 (en) 2004-02-18
EP1319005A2 (en) 2003-06-18
US6586421B2 (en) 2003-07-01
US20020107278A1 (en) 2002-08-08
JP2004509894A (en) 2004-04-02
WO2002024701A2 (en) 2002-03-28
AU2001292898A1 (en) 2002-04-02
WO2002024701A3 (en) 2002-06-13
US6583135B2 (en) 2003-06-24
EP1319004A2 (en) 2003-06-18
US20030220321A1 (en) 2003-11-27
US6828314B2 (en) 2004-12-07
PE20020510A1 (en) 2002-06-12
AR035493A1 (en) 2004-06-02
US6903090B2 (en) 2005-06-07
WO2002024700A2 (en) 2002-03-28
PE20020443A1 (en) 2002-05-16
US20030225058A1 (en) 2003-12-04
JP2004509893A (en) 2004-04-02

Similar Documents

Publication Publication Date Title
WO2002024700A3 (en) SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES
YU11501A (en) 4,4-biarylpiperidine derivatives with opioid receptor activity
WO2004026248A3 (en) Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
CA2534798A1 (en) Thiazole derivatives as cannabinoid receptor modulators
MXPA04002583A (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity.
CA2333703A1 (en) Isothiazole derivatives useful as anticancer agents
WO1999002502A3 (en) Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
PL367814A1 (en) 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
CA2031588A1 (en) Substituted cyclohexanols and cyclohexylamines as central nervous system agents
EA200600811A1 (en) NEW TETRAHYDROSPIRO {PIPERIDIN-2,7'-PYRROLO [3,2-b] PYRIDINE} DERIVATIVES AND NEW INDOLA DERIVATIVES, APPLICATION FOR THE TREATMENT OF DISORDERS RELATED TO 5-HT-RECEPTOR
EP1725536B8 (en) Imidazoline derivatives having cb1-antagonistic activity
WO2001017963A3 (en) Aminoalkoxy carbazoles and their use as 5-ht ligands
WO2002051832A3 (en) Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
CA2094703A1 (en) Substituted piperazines as central nervous system agents
CA2244777A1 (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
CA2420177A1 (en) Quinazoline derivatives as alpha-1 adrenergic antagonists
IL159880A0 (en) Arylsulfonyl derivatives with 5-ht6 receptor affinity
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
BG104983A (en) Aryl fused azapolycyclic compounds
AU3955199A (en) Remedies for itching containing PGD2 antagonists
BR9503572A (en) Compound pharmaceutical composition and method of treatment or prevention of a disease
BG106044A (en) Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
EP1142881A4 (en) Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives
NO973342L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001975267

Country of ref document: EP

Ref document number: 2002529110

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001975267

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001975267

Country of ref document: EP